Statins for the Treatment of Liver Fibrosis in Chronic Hepatitis-C Patients
Amina Abbassi, Ashok Kumar Lohano, Anwar Ali Jamali, Farah Mughul, Muhammad Khalid Shaikh, Muhammad Zain Shaikh & Arslan Ahmer · Journal of Pharmaceutical Research International · 2022
Background: Hepatitis C virus (HCV) is one of the most common causes of chronic liver disease and the leading indication for liver transplantation worldwide. Chronic hepatitis C (CHC) leads to cirrhosis and hepatocellular carcinoma (HCC). Statins have gained attention for their p...
Open access
Research Article
10.9734/jpri/2022/v34i4A35395